We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Types of ingredients permitted in nicotine-containing liquids in electronic cigarettes and refill containers.
How to make sure that you are providing the statistical data required as part of a clinical investigation of your medical device.
Information on the alignment of the amended UK clinical trial legislation with the Declaration of Helsinki, prioritising UK law where conflicts arise.
Information about Clinical Trials Regulations outlining expanded enforcement provisions, offences, and compliance requirements for sponsors and investigators.
From discovery to real-world impact, VDEC equips scientists with the expertise and facilities to navigate each step in the development of vaccines and therapeutics.
Information for people who wish to apply to release a vaccine or a blood product to market in the UK.
Guidance for organisations involved in any aspect of the pharmaceutical lifecycle or GLP studies regulated by MHRA, covering the approval of paper documents when working from home
What you need to do to supply investigational medicinal products (IMPs) from Great Britain to Northern Ireland.
The pre-clinical evaluation team at VDEC provides a safe and controlled environment to test new vaccines and therapeutics before they progress to clinical trials
Our Patient Involvement Strategy sets out how we will engage and involve the public and patients at every step of the regulatory journey.
Guidance for local partnerships on how to review adult drug and alcohol related deaths and near-fatal overdoses to prevent future deaths.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing, access and growth in 2025.
10 guiding principles that can inform the development of good machine learning practice (GMLP).
How to apply to have nutritional or dermatological products reviewed by the Advisory Committee on Borderline Substances (ACBS).
Resources for pharmacies to achieve Healthy Living Pharmacy (HLP) Level 1 status.
How the ‘Written Confirmation’ process operates for active substances manufactured in Great Britain (England, Wales and Scotland).
Report on the public health impact of nurses and midwives, dentists, allied health professionals and pharmacists.
Meningitis is a serious infection that can develop quickly and affect people of all ages
Guidance and advice for community pharmacies in England providing services to people who use drugs and alcohol.
AI Airlock programme develops industry and regulatory expert collaboration, bespoke testing plans, and improved regulatory understanding.
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).